| Identification | |
| Name: | Piperazine,1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-,hydrochloride (1:2) |
| Synonyms: | Piperazine,1-(p-tert-butylbenzyl)-4-(p-chloro-a-phenylbenzyl)-, dihydrochloride (6CI,7CI,8CI);Piperazine,1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-,dihydrochloride (9CI);1-(p-tert-Butylbenzyl)-4-(p-chlorodiphenylmethyl)piperazine dihydrochloride;1-p-Chlorobenzhydryl-4-p-(t)-butylbenzylpiperazine dihydrochloride;Bucladin S;Buclina;Buclizine dihydrochloride;Buclodin;Histabutyzine hydrochloride;Longifene;NSC 25141;Vibazine;Vibazine Hydrochloride; |
| CAS: | 129-74-8 |
| EINECS: | 204-962-4 |
| Molecular Formula: | C28H35Cl3N2 |
| Molecular Weight: | 433.03 |
| InChI: | InChI=1/C28H33ClN2.2ClH/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24;;/h4-16,27H,17-21H2,1-3H3;2*1H |
| Molecular Structure: |  |
| Properties | |
| Density: | g/cm3 |
| Appearance: | Off-White Powder |
| Specification: |
Buclizine hydrochloride (129-74-8) also can be called Bucladin-S ; Softran ; Piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-.alpha.-phenylbenzyl)-, dihydrochloride and 1-(p-Chlorobenzhydryl)-4-(p-tert-butylbenzyl)piperazine dihydrochloride . |
| Report: |
Reported in EPA TSCA Inventory. |
| Usage: |
Buclizine hydrochloride (129-74-8) is used as an antiemetic. |
| Safety Data | |
 |
|
